$10.75
-0.28-2.54%
At close: -
$10.70
-0.05-0.47%
After Hours: 6:19 PM EDT
Enfusion reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enfusion using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $0.05 | $0.06 | -16.7 % |
Jun 2024 | 2024-08-06 | $0.05 | $0.06 | -16.7 % |
Mar 2024 | 2024-05-09 | $0.06 | $0.04 | 50.0 % |
Dec 2023 | 2024-03-12 | $0.04 | $0.05 | -20.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $51.17M | $52.17M | -1.92 % |
Jun 2024 | 2024-08-06 | $49.46M | $50.05M | -1.19 % |
Mar 2024 | 2024-05-09 | $48.05M | $47.61M | 0.93 % |
Dec 2023 | 2024-03-12 | $46.49M | $45.27M | 2.69 % |
Enfusion (ENFN) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $0.05, which missed the estimate of $0.06.
The Actual Revenue was $51.2M, which missed the estimate of $52.2M.
Browse earnings estimates, EPS, and revenue on all stocks.